Contracts › W81XWH22C0005
W81XWH22C0005: FY20 New Start-JW200170: CNP8 Delivered Topically in a Tyrosine- Derived Fiber Mat to Reduce Burn Injury Progression, Speed Wound Closure, and Mitigate Scarring
Awarded to Neomatrix Therapeutics Inc by Defense Health Agency.
$2.9Mobligated
$2.9Mpotential value
08 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | W81XWH22C0005 |
|---|---|
| Awardee | Neomatrix Therapeutics Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | NY |
| Offers received | 1 |
| Period of performance | 09 September 2022 to 08 September 2026 |
| Potential end | 08 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record